Magle Chemoswed: Completed merger with Amniotics - Redeye

Redeye leaves a comment on the announced completion of the merger between Magle and Amniotics. we are encouraged to see Magle carry out this merger and argue that the potential benefits of the operation far outweigh the risks.

Länk till analysen i sin helhet: https://www.redeye.se/research/1042134/magle-chemoswed-completed-merger-with-amniotics?utm_source=finwire&utm_medium=RSS